Patents by Inventor Eric L. Schneider

Eric L. Schneider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXTENDED RELEASE HYDROGEL CONJUGATES OF C-NATRIURETIC PEPTIDES
    Publication number: 20240041982
    Abstract: Provided herein are extended release hydrogel conjugates of c-natriuretic peptides, methods of preparation thereof, and methods of use thereof.
    Type: Application
    Filed: November 24, 2021
    Publication date: February 8, 2024
    Applicant: ProLynx LLC
    Inventors: Eric L. SCHNEIDER, Brian R. HEARN, Daniel V. SANTI
  • IMPROVED CONJUGATION LINKERS
    Publication number: 20220280654
    Abstract: Provided are ?-eliminative linkers suitable for the conjugation of small molecule, peptide, and protein and compounds comprising the linkers.
    Type: Application
    Filed: April 3, 2020
    Publication date: September 8, 2022
    Applicant: ProLynx LLC
    Inventors: Gary W. ASHLEY, Brian HEARN, Shaun FONTAINE, Eric L. SCHNEIDER
  • EXTENDED RELEASE CONJUGATES OF EXENATIDE ANALOGS
    Publication number: 20200164083
    Abstract: Extended-release conjugates of stabilized GLP-1 agonists balance agonist stability with release rates to provide long lasting administration to treat diabetes and related conditions on once-a-month or less frequent dosing schedules.
    Type: Application
    Filed: March 16, 2017
    Publication date: May 28, 2020
    Applicant: ProLynx LLC
    Inventors: Eric L. SCHNEIDER, Brian HEARN, Jeffrey C. HENISE, Gary W. ASHLEY, Daniel V. SANTI
  • Conjugates of somatostatin analogues
    Patent number: 10413594
    Abstract: Conjugates of carriers and hydrogels for controlling the biological half-life of somatostatin and its analogs are disclosed.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: September 17, 2019
    Assignee: ProLynx LLC
    Inventors: Eric L. Schneider, Brian Hearn, Gary W. Ashley, Daniel V. Santi
  • Slow-release conjugates of SN-38
    Patent number: 10342792
    Abstract: Conjugates of SN-38 that provide optimal drug release rates and minimize the formation of the corresponding glucuronate are described. The conjugates release SN-38 from a polyethylene glycol through a ?-elimination mechanism.
    Type: Grant
    Filed: June 14, 2018
    Date of Patent: July 9, 2019
    Assignee: ProLynx LLC
    Inventors: Gary W. Ashley, Eric L. Schneider
  • CONJUGATES OF SOMATOSTATIN ANALOGUES
    Publication number: 20180296648
    Abstract: Conjugates of carriers and hydrogels for controlling the biological half-life of somatostatin and its analogs are disclosed.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 18, 2018
    Applicant: ProLynx LLC
    Inventors: Eric L. SCHNEIDER, Brian HEARN, Gary W. ASHLEY, Daniel V. SANTI
  • SLOW-RELEASE CONJUGATES OF SN-38
    Publication number: 20180289695
    Abstract: Conjugates of SN-38 that provide optimal drug release rates and minimize the formation of the corresponding glucuronate are described. The conjugates release SN-38 from a polyethylene glycol through a ?-elimination mechanism.
    Type: Application
    Filed: June 14, 2018
    Publication date: October 11, 2018
    Applicant: ProLynx LLC
    Inventors: Gary W. ASHLEY, Eric L. SCHNEIDER
  • Conjugates of somatostatin analogues
    Patent number: 10086049
    Abstract: Conjugates of carriers and hydrogels for controlling the biological half-life of somatostatin and its analogs are disclosed.
    Type: Grant
    Filed: October 22, 2014
    Date of Patent: October 2, 2018
    Assignee: ProLynx LLC
    Inventors: Eric L. Schneider, Brian Hearn, Gary W. Ashley, Daniel V. Santi
  • Slow-release conjugates of SN-38
    Patent number: 10016411
    Abstract: Conjugates of SN-38 that provide optimal drug release rates and minimize the formation of the corresponding glucuronate are described. The conjugates release SN-38 from a polyethylene glycol through a ?-elimination mechanism.
    Type: Grant
    Filed: October 3, 2014
    Date of Patent: July 10, 2018
    Assignee: ProLynx LLC
    Inventors: Gary W. Ashley, Eric L. Schneider
  • CONJUGATES OF SOMATOSTATIN ANALOGUES
    Publication number: 20160271227
    Abstract: Conjugates of carriers and hydrogels for controlling the biological half-life of somatostatin and its analogs are disclosed.
    Type: Application
    Filed: October 22, 2014
    Publication date: September 22, 2016
    Applicant: ProLynx LLC
    Inventors: Eric L. SCHNEIDER, Brian HEARN, Gary W. ASHLEY, Daniel V. SANTI
  • SLOW-RELEASE CONJUGATES OF SN-38
    Publication number: 20160243106
    Abstract: Conjugates of SN-38 that provide optimal drug release rates and minimize the formation of the corresponding glucuronate are described. The conjugates release SN-38 from a polyethylene glycol through a ?-elimination mechanism.
    Type: Application
    Filed: October 3, 2014
    Publication date: August 25, 2016
    Applicant: ProLynx LLC
    Inventors: Gary W. ASHLEY, Eric L. SCHNEIDER
  • Antibodies and methods of use thereof
    Patent number: 9309325
    Abstract: The disclosure relates to protease-binding agent specific for a protease. The agent may be an antibody capable of specifically binding and inhibiting a protease, such as a P1-Arg-specific protease. The disclosure also provides methods of producing, and compositions comprising the subject agent. Methods and kits related to the protease-binding agent find use in protection against, detection, diagnosing, treating cancer and infections due to pathogens containing active proteases.
    Type: Grant
    Filed: May 4, 2010
    Date of Patent: April 12, 2016
    Assignee: The Regents of the University of California
    Inventors: Charles S. Craik, Eric L. Schneider
  • PEG CONJUGATES OF EXENATIDE
    Publication number: 20140256626
    Abstract: Slow release forms of exenatide wherein exenatide is releasably linked to polyethylene glycol carriers are disclosed.
    Type: Application
    Filed: October 17, 2012
    Publication date: September 11, 2014
    Inventors: Daniel V. Santi, Eric L. Schneider, Gary W. Ashley
  • Antibodies and Methods of Use Thereof
    Publication number: 20120141373
    Abstract: The disclosure relates to protease-binding agent specific for a protease. The agent may be an antibody capable of specifically binding and inhibiting a protease, such as a P1-Arg-specific protease. The disclosure also provides methods of producing, and compositions comprising the subject agent. Methods and kits related to the protease-binding agent find use in protection against, detection, diagnosing, treating cancer and infections due to pathogens containing active proteases.
    Type: Application
    Filed: May 4, 2010
    Publication date: June 7, 2012
    Inventors: Charles S. Craik, Eric L. Schneider